Date Filed | Type | Description |
08/24/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.9% stake in Gamida Cell Ltd. |
08/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.8% stake in IO Biotech, Inc. |
08/10/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Alimera Sciences, Inc. |
06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.4% stake in Evolus, Inc. |
06/16/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 10% stake in Aytu BioPharma, Inc. |
06/09/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 7.6% stake in Scynexis, Inc. |
04/14/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/18/2023 |
SC 13G
| Stonepine Capital Management, LLC reports a 5.3% stake in Third Harmonic Bio, Inc. |
12/02/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Adamas Pharmaceuticals, Inc. |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 5.3% stake in Exagen Inc. |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 10% stake in CTI BioPharma Corp. |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 6.5% stake in Apollo Endosurgery, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 7.9% stake in Conformis, Inc. |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Yumanity Therapeutics, Inc. |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 0% stake in Catalyst Biosciences, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 1.6% stake in SCYNEXIS, Inc. |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/11/2022 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 5.3% stake in DiaMedica Therapeutics Inc. |
|